2.4(top 20%)
impact factor
23.3K(top 1%)
242.1K(top 2%)
152(top 2%)
2.5(top 20%)
extended IF
all documents
doc citations
211(top 5%)

Top Articles

1Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomised clinical trialsLung Cancer1996741
2Reliability and validity of the functional assessment of cancer therapy—lung (FACT-L) quality of life instrumentLung Cancer1995652
3Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumabLung Cancer2017631
4Metastatic sites and survival in lung cancerLung Cancer2014590
5Carcinoembryonic antigen (CEA) as tumor marker in lung cancerLung Cancer2012556
6Tobacco smoking and cancer: a brief review of recent epidemiological evidenceLung Cancer2004553
7EGFR mutation detection in ctDNA from NSCLC patient plasma: A cross-platform comparison of leading technologies to support the clinical development of AZD9291Lung Cancer2015454
8Endobronchial ultrasound guided transbronchial needle aspiration for staging of lung cancerLung Cancer2005445
9Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancerLung Cancer1998434
10Complete resection in lung cancer surgery: proposed definitionLung Cancer2005417
11Effect of cigarette smoking on major histological types of lung cancer: a meta-analysisLung Cancer2001407
12Pretreatment neutrophil-to-lymphocyte ratio as a marker of outcomes in nivolumab-treated patients with advanced non-small-cell lung cancerLung Cancer2017403
13Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized studyLung Cancer2004400
14Prognostic significance of tumor infiltrating natural killer cells subset CD57 in patients with squamous cell lung cancerLung Cancer2002392
15Chemotherapy, chemoresistance and the changing treatment landscape for NSCLCLung Cancer2011381
16Brain metastases in patients with EGFR -mutated or ALK -rearranged non-small-cell lung cancersLung Cancer2015369
17Preresectional chemotherapy in stage IIIA non-small-cell lung cancer: a 7-year assessment of a randomized controlled trialLung Cancer1999367
18Radiomics and radiogenomics in lung cancer: A review for the clinicianLung Cancer2018362
19An electronic nose in the discrimination of patients with non-small cell lung cancer and COPDLung Cancer2009357
20Staging small cell lung cancer: Veterans Administration Lung Study Group versus International Association for the Study of Lung Cancer—what limits limited disease?Lung Cancer2002327
21Phosphorylated Akt overexpression and loss of PTEN expression in non-small cell lung cancer confers poor prognosisLung Cancer2006322
22A randomized trial of systematic nodal dissection in resectable non-small cell lung cancerLung Cancer2002320
23The relationship between COPD and lung cancerLung Cancer2015320
24Estimation of tumor control probability model parameters from 3-D dose distributions of non-small cell lung cancer patientsLung Cancer1999314
25Nodule management protocol of the NELSON randomised lung cancer screening trialLung Cancer2006313
26Correlation between immune-related adverse events and efficacy in non-small cell lung cancer treated with nivolumabLung Cancer2018313
27Angiogenesis in non-small cell lung cancer: The prognostic impact of neoangiogenesis and the cytokines VEGF and bFGF in tumours and bloodLung Cancer2006310
28Establishment and identification of small cell lung cancer cell lines having classic and variant featuresLung Cancer1986308
29Efficacy of epidermal growth factor receptor tyrosine kinase inhibitors for brain metastasis in non-small cell lung cancer patients harboring either exon 19 or 21 mutationLung Cancer2012308
30Evaluation of F-18 fluorodeoxyglucose (FDG) PET scanning for pulmonary nodules less than 3 cm in diameter, with special reference to the CT imagesLung Cancer2004304
31Cisplatin and gemcitabine first-line chemotherapy followed by maintenance gemcitabine or best supportive care in advanced non-small cell lung cancer: A phase III trialLung Cancer2006304
32International trends in lung cancer incidence by histological subtype: Adenocarcinoma stabilizing in men but still increasing in womenLung Cancer2014303
33Distress screening in a multidisciplinary lung cancer clinic: Prevalence and predictors of clinically significant distressLung Cancer2007301
34Altered miRNA expression in sputum for diagnosis of non-small cell lung cancerLung Cancer2010301
35Tumour-stroma interaction: cancer-associated fibroblasts as novel targets in anti-cancer therapy?Lung Cancer2004297
36MiR-126 restoration down-regulate VEGF and inhibit the growth of lung cancer cell lines in vitro and in vivoLung Cancer2009297
37A multicenter, randomized, phase III study of docetaxel plus best supportive care versus best supportive care in chemotherapy-naive patients with metastatic or non-resectable localized non-small cell lung cancer (NSCLC)Lung Cancer2000293
38B7-H3 and B7-H4 expression in non-small-cell lung cancerLung Cancer2006290
39Phase II clinical study of photodynamic therapy using mono-l-aspartyl chlorin e6 and diode laser for early superficial squamous cell carcinoma of the lungLung Cancer2003289
40KRAS mutations and resistance to EGFR-TKIs treatment in patients with non-small cell lung cancer: A meta-analysis of 22 studiesLung Cancer2010289
41The role of radiotherapy in treatment of stage I non-small cell lung cancerLung Cancer2003283
42Phase II study of a multidisciplinary approach with induction chemotherapy, followed by surgical resection, radiation therapy, and consolidation chemotherapy for unresectable malignant thymomas: final reportLung Cancer2004282
43Final results of the Lung Screening Study, a randomized feasibility study of spiral CT versus chest X-ray screening for lung cancerLung Cancer2005278
44Prognosis of 6644 resected non-small cell lung cancers in Japan: A Japanese lung cancer registry studyLung Cancer2005276
45An investigation on electronic nose diagnosis of lung cancerLung Cancer2010271
46Stereotactic body radiation therapy for early stage non-small cell lung cancer: Results of a prospective trialLung Cancer2010268
47Is there an oligometastatic state in non-small cell lung cancer? A systematic review of the literatureLung Cancer2013268
48Prevalence of co-morbidity in lung cancer patients and its relationship with treatment: A population-based studyLung Cancer1998266
49Design, recruitment and baseline results of the ITALUNG trial for lung cancer screening with low-dose CTLung Cancer2009265
50Efficacy of gemcitabine plus platinum chemotherapy compared with other platinum containing regimens in advanced non-small-cell lung cancer: a meta-analysis of survival outcomesLung Cancer2005263